SCHEMBL6537541

SCHEMBL6537541

C=CCOc1ccnc2c(N)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
CYP2A6 P11509 1/20 0.40
SETDB1 Q15047 1/20 0.39
NR4A2 P43354 1/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA9 Q16790 2/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
APAF1 O14727 1/20 0.37
TDP2 O95551 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
PARP1 P09874 1/20 0.36
HPGD P15428 3/20 0.36
NSD2 O96028 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12474991 0.80 ALDH1A1 (0.50) NR4A2CA12CA1CA9ALDH1A1
SCHEMBL8545669 0.79 PARP1 (0.48) CYP3A4CYP2A6PARP1
SCHEMBL20554725 0.79 CYP3A4 (0.49) CYP3A4CYP2A6SETDB1NR4A2CA12
SCHEMBL6537863 0.76 ALDH1A1 (0.55) CYP3A4CYP2A6CA12CA1CA9
SCHEMBL6537540 0.76 PLAU (0.51) MAPTMAPK1SMN1; SMN2
SCHEMBL7247375 0.76 NSD2 (0.54) NR4A2ALDH1A1MAPTMEN1KMT2A
SCHEMBL8545328 0.75 ALDH1A1 (0.58) CYP3A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL14075127 0.74 SETDB1 (0.48) CYP3A4CYP2A6SETDB1CA12CA1
SCHEMBL3820470 0.74 CYP3A4 (0.57) CYP3A4CYP2A6SETDB1CA12CA1
SCHEMBL10366160 0.73 PSMD14 (0.53) CYP3A4CYP2A6SETDB1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed